Please select a format
Price

Single User License Pirce
USD 900
Hard Copy Lincense Price
USD 1200
Corporate User Lincense Price
USD 1600

Alternatively

Request a quote
Request a Customized research
Request for Sample Report



Recent Viewed Reports


Why Ken Reasearch?


Testimonials

We commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights. ... "Owner, Therefore Consulting"


India In-Vitro Diagnostics Industry Analysis till 2018 - Accreditation and Automation to Drive Future Growth

  • Products Id :- KR90
  • |
  • Pages: 129
  • |
  • October 2013
  • |
  • Ken Research
  • |
  • Market Research Report
  Request for Sample Report

Executive Summary

The report titled “India In-Vitro Diagnostics Industry Analysis till 2018 – Accreditation and Automation to Drive Future Growth” provides a comprehensive analysis of the various aspects such as market size of the India in-vitro diagnostics market, India immunochemistry market, India biochemistry market, India hematology market, India microbiology market, India blood gas and electrolyte market, India molecular diagnostics market, India urinalysis market and India coagulation market. The report also covers the market shares of major players in the immunochemistry, biochemistry and microbiology space as well as the overall in-vitro diagnostics market in India.

In-vitro diagnostics market in India, which has hugely been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, government’s initiatives and improving healthcare infrastructure, registered revenues of USD ~ million in FY’2013. With the advent of new varieties of diagnostic tests incorporating latest technology, the revenues increased by 25.8% compared to FY’2012, where the total revenues were USD ~ million. In-vitro diagnostics market in India is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases, and the overall disposable incomes in the country, which play an important role in determining the revenues from various diagnostic segments. Immunochemistry was the largest contributing category in terms of revenue, having recorded sales of USD ~ million in fiscal year 2013, while biochemistry, hematology and microbiology also contributed a significant share to the overall revenues. The India in-vitro diagnostics market has grown at a CAGR of 19.4% from USD 303.2 million in FY’2007 to USD ~ million in FY’2013.

The in-vitro diagnostics market in India is comprised of various manufacturers that specialize in the development and production of diagnostic products in different segments. Along with the presence of leading diagnostic companies in the organized sector, market in India is also driven by the revenues of a huge number of manufacturers in the unorganized segment. Roche was the market leader in the overall IVD market India, while also dominating the immunochemistry and biochemistry segments in fiscal year 2013. In addition to the prevalence of several players in the organized segment, the market is also driven by the imports of numerous diagnostic products from China and other countries

In-vitro diagnostics market in India has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily, and have been adopting fully automated systems for diseases diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in India.

The market for in-vitro diagnostics in India is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population, and people suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized to the organized segment have been significantly changing the market. Revenues from the in-vitro diagnostics market in India are expected to expand to USD ~ million in FY’2018, growing with a CAGR of ~% from FY’2013 to FY’2018.

Key Topics Covered in the Report:

- The market size of the India in-vitro diagnostics market.

- The market size of the India immunochemistry market.

- The market size of the India immunochemistry reagents and instruments.

- The market size of the India biochemistry market.

- The market size of the India hematology market.

- The market size of the India microbiology market.

- Market segmentation of the India in-vitro diagnostics market on the basis of type of tests, contribution from reagents and instruments, and contribution from urban and rural areas.

- Market segmentation of the India Immunochemistry market on the basis of contribution from reagents and instruments, ELISA kits and rapid tests, and the market segmentation of immunochemistry instruments and reagents by types of tests and end use.

- Market segmentation of the India biochemistry market on the basis of contribution from reagents and instruments.

- Market segmentation of the India hematology market on the basis of contribution from reagents and instruments.

- Market segmentation of the India microbiology market on the basis of contribution from reagents and instruments.

- Market segmentation of the India blood gas and electrolyte market on the basis of contribution from reagents and instruments.

- Market segmentation of the India molecular diagnostics market on the basis of contribution from reagents and instruments.

- Market segmentation of the India urinalysis market on the basis of contribution from reagents and instruments.

- Market segmentation of the India coagulation market on the basis of contribution from reagents and instruments.

- Trends and Development in the India in-vitro diagnostics market.

- Competitive landscape and detailed company profiles of the major manufacturers of diagnostics products in India

- Future outlook and projections of the India in-vitro diagnostics market.

1. India In-Vitro Diagnostics Market Introduction

Market Overview

Growth Drivers

Constraints

Regulatory Framework and Accreditation

2. India In-Vitro Diagnostics Market Size by Revenues, FY’2007-FY’2013

3. India In-Vitro Diagnostics Market Segmentation

3.1. By Reagents and Instruments, FY’2010-FY’2013

3.2. By Urban and Rural Areas, FY’2013

3.3. By Type of Tests, FY’2007-FY’2013

4. India Immunochemistry Market

4.1. Market Scenario

Market Overview

Drivers

Constraints

Emerging Technology Trends

4.2. India Immunochemistry Market Size, FY’2007- FY’2013

4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY’2007-FY’2013

4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY’2007-FY’2013

4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY’2007-FY’2013

4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY’2007-FY’2013

4.4. Market Share of Major Players in India Immunochemistry Market, FY’2013

5. India Biochemistry Market

5.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

5.2. India Biochemistry Market Size, FY’2007 – FY’2013

5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

5.4. Market Share of Major Players in India Biochemistry Market, FY’2013

6. India Hematology Market

6.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

6.2. India Hematology Market Size, FY’2007-FY’2013

6.3. India Hematology Market Segmentation By Reagents and Instruments, FY’2007-FY’2013

6.4. India Hematology Market Competitive Landscape

7. India Microbiology Market

7.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

7.2. India Microbiology Market Size, FY’2007-FY’2013

7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY’2008-FY’2013

7.4. Market Share of Major Players in India Microbiology Market, FY’2013

8. India Blood Gas and Electrolyte Market

8.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

8.2. India Blood Gas and Electrolyte Market Size, FY’2007 - FY’2013

8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY’2013

9. India Molecular Diagnostics Market

9.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

9.2. India Molecular Diagnostics Market Size, FY’2007 - FY’2013

9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

10. India Urinalysis Market

10.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

10.2. India Urinalysis Market Size, FY’2007 - FY’2013

10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

11. India Coagulation Diagnostics Market

11.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

11.2. India Coagulation Diagnostics Market Size, FY’2007 – FY’2013

11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

12. India In-Vitro Diagnostics Market Trends and Developments

Mounting Demand for Decentralized Laboratory Tests

Increasing Penetration in Rural Areas

Early Detection as an Emerging Trend

Inclining Automation of Labs

Increasing Consolidation

Increasing Overseas Expansion

Inclining Prevalence of Hospital Laboratory Management (HLM)

13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY’2013

14. Company Profiles of Major Players in India In-Vitro Diagnostics Market

15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY’2014-FY’2018

15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India

16. Macroeconomic and Industry Factors: Historical and Projections

16.1. Population in India, FY’2007-FY’2018

16.2. Personal Disposable Income in India, FY’2007-FY’2018

16.3. Consumer Expenditure on Healthcare in India, FY’2007-FY’2018

16.4. Government Expenditure on Healthcare in India, FY’2007-FY’2018

16.5. Foreign Direct Investments in Healthcare, FY’2008-FY’2013

16.6. Private Equity Investments in Healthcare, 2009-2012

17. Appendix

17.1. Market Definitions

17.2. Abbreviations

17.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent)

Final Conclusion

17.4. Disclaimer

Figure 1: India In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY’2010-FY’2013

Figure 3: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Urban and Rural Areas in Percentage, FY’2013

Figure 4: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in Percentage, FY’2007-FY’2013

Figure 5: India Immunochemistry Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 6: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in Percentage, FY’2007-FY’2013

Figure 7: India Immunochemistry Instruments and Reagents Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 8: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY’2007-FY’2013

Figure 9: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Different Types of Instruments and Reagents in Percentage, FY’2007-FY’2013

Figure 10: India Immunochemistry Reagents Market Segmentation on the Basis of Revenues from End Use in Different Types of Diagnostic Tests in Percentage, FY’2007-FY’2013

Figure 11: India Biochemistry Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 12: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013

Figure 13: India Biochemistry Instruments Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY’2011-FY’2013

Figure 14: Market Share of Major Players on the Basis of Revenues in the Biochemistry Market in India in Percentage, FY’2013

Figure 15: India Hematology Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 16: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013

Figure 17: India Hematology Instruments Market Segmentation on the Basis of Revenues from Different Type of Instruments in Percentage, FY’2009-FY’2012

Figure 18: India Microbiology Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 19: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2008-FY’2013

Figure 20: India Blood Gas and Electrolyte Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 21: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in Percentage, FY’2007-FY’2013

Figure 22: India Blood Gas and Electrolyte Analyzers Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY’2009-FY’2013

Figure 23: Market Share of Major Players on the Basis of Revenues in the Blood Gas and Electrolyte Market in Percentage, FY’2013

Figure 24: India Molecular Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY2013

Figure 25: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013

Figure 26: India Urinalysis Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 27: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013

Figure 28: India Coagulation Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013

Figure 29: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013

Figure 30: Market Share of Major Players on the Basis of Revenues in the India In-Vitro Diagnostics Market in Percentage, FY’2013

Figure 31: India In-Vitro Diagnostics Market Future Projections on the Basis of Revenues in USD Million, FY’2014-FY’2018

Figure 32: Population in India in Million, FY’2007-FY’2018

Figure 33: Personal Disposable Incomes in India in USD Million, FY’2007-FY’2018

Figure 34: Consumer Expenditure on Healthcare and Medical Services in India in USD Million, FY’2007-FY’2018

Figure 35: Government Expenditure on Health Care in India in USD Million, FY’2007-FY’2018

Figure 36: Foreign Direct Investment in Healthcare Sector in India in USD Million, FY’2008-FY’2013

Figure 37: Private Equity Investments in Healthcare Sector in India in USD Million, 2009-2012

Table 1: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY’2010-FY’2013

Table 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in USD Million, FY’2007-FY’2013

Table 3: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in USD Million, FY’2007-FY’2013

Table 4: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in USD Million, FY’2007-FY’2013

Table 5: Market Share of Major Players on the Basis of Revenues in the Immunochemistry Market in India in Percentage, FY’2013

Table 6: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2007-FY’2013

Table 7: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2007-FY’2013

Table 8: Major Players in Hematology Instruments and Reagents Market in India

Table 9: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2008-FY’2013

Table 10: Market Share of Major Players on the Basis of Revenues in the Hematology Reagents Market in Percentage, FY’2013

Table 11: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in USD Million, FY’2007-FY’2013

Table 12: Major Players in the India Blood Gas and Electrolyte Market

Table 13: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2007-FY’2013

Table 14: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2007-FY’2013

Table 15: India Urinalysis Analyzers Market Segmentation on the Basis of Sales Quantity of Different Analyzers in Units and Percentage USD Million, FY’2012

Table 16: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in USD Million, FY’2007-FY’2013

Table 17: Company Profile of Major Players (Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex) in India In-Vitro Diagnostic Market

Table 18: Cause and Effect Relationship Analysis between Industry Factors and Expected In-Vitro Diagnostics Market Prospects in India

Table 19: India Population Segmentation on the Basis of People Residing in Urban and Rural Areas in Million, FY’2007-FY’2013

Table 20: Correlation Matrix of the India In-Vitro Diagnostics Market

Table 21: Regression Coefficients Output

India In-Vitro Diagnostics Industry Analysis till 2018- Introduction Pages : 6| USD 100

1. India In-Vitro Diagnostics Market Introduction

Market Overview

Growth Drivers

Constraints

Regulatory Framework and Accreditation

India In-Vitro Diagnostics Industry Analysis till 2019- Market Size Pages : 9| USD 200

2. India In-Vitro Diagnostics Market Size by Revenues, FY’2007-FY’2013

3. India In-Vitro Diagnostics Market Segmentation

3.1. By Reagents and Instruments, FY’2010-FY’2013

3.2. By Urban and Rural Areas, FY’2013

3.3. By Type of Tests, FY’2007-FY’2013

India In-Vitro Diagnostics Industry Analysis till 2020- Immunochemistry Market Pages : 11| USD 200

4. India Immunochemistry Market

4.1. Market Scenario

Market Overview

Drivers

Constraints

Emerging Technology Trends

4.2. India Immunochemistry Market Size, FY’2007- FY’2013

4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY’2007-FY’2013

4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY’2007-FY’2013

4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY’2007-FY’2013

4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY’2007-FY’2013

4.4. Market Share of Major Players in India Immunochemistry Market, FY’2013

India In-Vitro Diagnostics Industry Analysis till 2021- Biochemistry Market Pages : 7| USD 150

5. India Biochemistry Market

5.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

5.2. India Biochemistry Market Size, FY’2007 – FY’2013

5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

5.4. Market Share of Major Players in India Biochemistry Market, FY’2013

India In-Vitro Diagnostics Industry Analysis till 2022- Hematology Market Pages : 8| USD 150

6. India Hematology Market

6.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

6.2. India Hematology Market Size, FY’2007-FY’2013

6.3. India Hematology Market Segmentation By Reagents and Instruments, FY’2007-FY’2013

6.4. India Hematology Market Competitive Landscape

India In-Vitro Diagnostics Industry Analysis till 2023- Microbiology Market Pages : 7| USD 150

7. India Microbiology Market

7.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

7.2. India Microbiology Market Size, FY’2007-FY’2013

7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY’2008-FY’2013

7.4. Market Share of Major Players in India Microbiology Market, FY’2013

India In-Vitro Diagnostics Industry Analysis till 2024- Blood Gas and Electrolyte Market Pages : 8| USD 150

8. India Blood Gas and Electrolyte Market

8.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

8.2. India Blood Gas and Electrolyte Market Size, FY’2007 - FY’2013

8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY’2013

India In-Vitro Diagnostics Industry Analysis till 2025- Urinalysis Market Pages : 7| USD 150

10. India Urinalysis Market

10.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

10.2. India Urinalysis Market Size, FY’2007 - FY’2013

10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

India In-Vitro Diagnostics Industry Analysis till 2025- Coagulation Diagnostics Market Pages : 6| USD 150

11. India Coagulation Diagnostics Market

11.1. Market Scenario

Market Overview

Growth Drivers

Constraints

Trends

11.2. India Coagulation Diagnostics Market Size, FY’2007 – FY’2013

11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013

India In-Vitro Diagnostics Industry Analysis till 2025- Urinalysis Market- Trends and Competition Pages : 11| USD 150

12. India In-Vitro Diagnostics Market Trends and Developments

Mounting Demand for Decentralized Laboratory Tests

Increasing Penetration in Rural Areas

Early Detection as an Emerging Trend

Inclining Automation of Labs

Increasing Consolidation

Increasing Overseas Expansion

Inclining Prevalence of Hospital Laboratory Management (HLM)

13. Market Share of Major Players in India In-Vitro Diagnostics Market, FY’2013

14. Company Profiles of Major Players in India In-Vitro Diagnostics Market

India In-Vitro Diagnostics Industry Analysis till 2025- Outlook and Macro Pages : 12| USD 150

15. India In-Vitro Diagnostics Market Future Outlook and Projections, FY’2014-FY’2018

15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India

16. Macroeconomic and Industry Factors: Historical and Projections

16.1. Population in India, FY’2007-FY’2018

16.2. Personal Disposable Income in India, FY’2007-FY’2018

16.3. Consumer Expenditure on Healthcare in India, FY’2007-FY’2018

16.4. Government Expenditure on Healthcare in India, FY’2007-FY’2018

16.5. Foreign Direct Investments in Healthcare, FY’2008-FY’2013

16.6. Private Equity Investments in Healthcare, 2009-2012

 

Roche Diagnostic, Abbott Laboratories, Transasia Biomedicals, Siemens Healthcare, Beckman Coulter, Becton and Dickinson and Sysmex

in-vitro diagnostics, immunochemistry, reagents and instruments, coagulation, biochemistry, hematology, microbiology, ELISA kits and rapid tests, micr


Contact Us
Ken Research Pvt. Ltd. 109-110, NDM II, Netaji Subhash Place, Pitampura, New Delhi - 110034, India
01147017199, +91 9015378249

download

Company Brochure

Give us a Ring

01147017199

Engage with Us

query@kenresearch.com

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>